Tacrolimus/mycophenolate provides superior immunosuppression relative to neoral/mycophenolate in synchronous pancreas-kidney transplantation

Transplantation Proceedings

Volumn 30, Issue 4, 1998, Pages 1538-1540

  Bruce, D S ^a   Woodle, E S ^a   Newell, K A ^a   Millis, J M ^a   Cronin II, D C ^a   Loss, G E ^a   Grewal, H P ^a   Siegel, C T ^a   Pellar, S ^a   Josephson, M A ^a   Thistlethwaite Jr , J R ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS;

ALLOGRAFT; CONFERENCE PAPER; GRAFT REJECTION; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; PANCREAS TRANSPLANTATION; PRIORITY JOURNAL; RECIPIENT;

BIOLOGICAL AVAILABILITY; CYCLOSPORINE; DRUG THERAPY, COMBINATION; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MYCOPHENOLIC ACID; PANCREAS TRANSPLANTATION; RECURRENCE; RETROSPECTIVE STUDIES; SURVIVAL RATE; TACROLIMUS;

EID: 13144294994     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(98)00348-0     Document Type: Conference Paper

References (10)

1. European Mycophenolate Mofetil Cooperative Study Group: Lancet 345:1321, 1995
2. Sollinger HW, Beizer FO, Deierhoi MH, et al: Annal Surg 216:513, 1992
3. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group: Transplantation 61:1029, 1996
4. European FK506 Multicentre Liver Study Group: Lancet 344:423, 1994
5. U.S. Multicenter FK506 Liver Study Group: N Engl J Med 331:1110, 1994
6. Laskow DA, Vincenti F, Neylan JF, et al: Transplantation 62:900, 1996
7. Elkhammas EA, Yilmaz S, Henry ML, et al: Acta Diabetologica 34:161, 1997
8. Bruce DS, Woodle ES, Newell KA, et al: Acta Diabetologica 34:161, 1997
9. Tesi RJ, Henry ML, Elkhammas EA, et al: Transplantation 58:424, 1994
10. Bruce DS, Newell KA, Josephson MA, et al: Transplantation 62:451, 1996